The Hox genes and their roles in oncogenesis

Nature Reviews Cancer

Volumn 10, Issue 5, 2010, Pages 361-371

  Shah, Nilay ^a   Sukumar, Saraswati ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOX PROTEIN; NUCLEOPORIN 98; TAMOXIFEN;

ANGIOGENESIS; APOPTOSIS; BREAST CANCER; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER INHIBITION; CANCER THERAPY; CARCINOGENESIS; CELL DIFFERENTIATION; CELL INVASION; CELL MOTILITY; CELL PROLIFERATION; CELL TRANSFORMATION; CHROMOSOME ABERRATION; DEREGULATION; EPIGENETICS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; HOX GENE; HUMAN; LEUKEMIA; LUNG CARCINOMA; NEUROBLASTOMA; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; PROSTATE CARCINOMA; REVIEW; SIGNAL TRANSDUCTION; UTERINE CERVIX CARCINOMA;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; GENES, HOMEOBOX; HUMANS; NEOPLASMS;

EID: 77951605788     PISSN: 1474175X     EISSN: 14741768     Source Type: Journal    
DOI: 10.1038/nrc2826     Document Type: Review

References (139)

1. Bridges, C. B. Current maps of the location of the mutant genes of Drosophila Melanogaster. Proc. Natl Acad. Sci. USA 7, 127-132 (1921).
2. Shen, W. F., Krishnan, K., Lawrence, H. J. & Largman, C. The HOX homeodomain proteins block CBP histone acetyltransferase activity. Mol. Cell. Biol. 21, 7509-7522 (2001).
3. Dolle, P., Izpisua-Belmonte, J. C., Brown, J., Tickle, C. & Duboule, D. Hox genes and the morphogenesis of the vertebrate limb. Prog. Clin. Biol. Res. 383A, 11-20 (1993).
4. Mortlock, D. P. & Innis, J. W. Mutation of HOXA13 in hand-foot-genital syndrome. Nature Genet. 15, 179-180 (1997).
5. Perez-Cabrera, A., Kofman-Alfaro, S. & Zenteno, J. C. Mutational analysis of HOXD13 and HOXA13 genes in the triphalangeal thumb- brachyectrodactyly syndrome. J. Orthop. Res. 20, 899-901 (2002).
6. Zacchetti, G., Duboule, D. & Zakany, J. Hox gene function in vertebrate gut morphogenesis: the case of the caecum. Development 134, 3967-3973 (2007).
7. Cardoso, W. V. Transcription factors and pattern formation in the developing lung. Am. J. Physiol. 269, L429-L442 (1995).
8. Simpson, J. L. Genetics of the female reproductive ducts. Am. J. Med. Genet. 89, 224-239 (1999).
9. Wellik, D. M. Hox genes and vertebrate axial pattern. Curr. Top. Dev. Biol. 88, 257-278 (2009).
10. Jung, C., Kim, R. S., Lee, S. J., Wang, C. & Jeng, M. H. HOXB13 homeodomain protein suppresses the growth of prostate cancer cells by the negative regulation of T-cell factor 4. Cancer Res. 64, 3046-3051 (2004).
11. Economides, K. D. & Capecchi, M. R. Hoxb13 is required for normal differentiation and secretory function of the ventral prostate. Development 130, 2061-2069 (2003).
12. Wang, Z. et al. The prognostic biomarkers HOXB13, IL17BR, and CHDH are regulated by estrogen in breast cancer. Clin. Cancer Res. 13, 6327-6334 (2007).
13. Calvo, K. R., Sykes, D. B., Pasillas, M. P. & Kamps, M. P. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1. Oncogene 21, 4247-4256 (2002).
14. Zhang, X. et al. HOXC6 and HOXC11 increase transcription of S100beta gene in BrdU-induced in vitro differentiation of GOTO neuroblastoma cells into Schwannian cells. J. Cell. Mol. Med. 11, 299-306 (2007).
15. Chen, H. et al. HOXA5 acts directly downstream of retinoic acid receptor beta and contributes to retinoic acid-induced apoptosis and growth inhibition. Cancer Res. 67, 8007-8013 (2007).
16. Miao, J. et al. HOXB13 promotes ovarian cancer progression. Proc. Natl Acad. Sci. USA 104, 17093-17098 (2007).
17. Wu, X. et al. HOXB7, a homeodomain protein, is overexpressed in breast cancer and confers epithelial-mesenchymal transition. Cancer Res. 66, 9527-9534 (2006).
18. Zhai, Y. et al. Gene expression analysis of preinvasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasion. Cancer Res. 67, 10163-10172 (2007).
19. Abate-Shen, C. Deregulated homeobox gene expression in cancer: cause or consequence? Nature Rev. Cancer 2, 777-785 (2002).
20. Hershko, A. Y., Kafri, T., Fainsod, A. & Razin, A. Methylation of HoxA5 and HoxB5 and its relevance to expression during mouse development. Gene 302, 65-72 (2003).
21. Rauch, T. et al. Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay. Proc. Natl Acad. Sci. USA 104, 5527-5532 (2007).
22. Fanti, L. et al. The trithorax group and Pc group proteins are differentially involved in heterochromatin formation in Drosophila. Chromosoma 11 7, 25-39 (2008).
23. Hanson, R. D. et al. Mammalian Trithorax and polycomb-group homologues are antagonistic regulators of homeotic development. Proc. Natl Acad. Sci. USA 96, 14372-14377 (1999).
24. Krivtsov, A. V. & Armstrong, S. A. MLL translocations, histone modifications and leukaemia stem-cell development. Nature Rev. Cancer 7, 823-833 (2007).
25. Ferrando, A. A. et al. Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation. Blood 102, 262-268 (2003).
26. Armstrong, S. A., Golub, T. R. & Korsmeyer, S. J. MLL-rearranged leukemias: insights from gene expression profiling. Semin. Hematol. 40, 268-273 (2003).
27. Golub, T. R. et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286, 531-537 (1999).
28. Faber, J. et al. HOXA9 is required for survival in human MLL-rearranged acute leukemias. Blood 11 3, 2375-2385 (2009).
29. Yekta, S., Tabin, C. J. & Bartel, D. P. MicroRNAs in the Hox network: an apparent link to posterior prevalence. Nature Rev. Genet. 9, 789-796 (2008).
30. Chopra, V. S. & Mishra, R. K. "Mir"acles in hox gene regulation. Bioessays 28, 445-448 (2006).
31. Stark, A. et al. A single Hox locus in Drosophila produces functional microRNAs from opposite DNA strands. Genes Dev. 22, 8-13 (2008).
32. Weiss, F. U. et al. Retinoic acid receptor (RAR) antagonists inhibit miR-10a expression and block metastatic behaviour of pancreatic cancer. Gastroenterology 137, 2136-2145 (2009).
33. Popovic, R. et al. Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization. Blood 11 3, 3314-3322 (2009).
34. Han, L., Witmer, P. D., Casey, E., Valle, D. & Sukumar, S. DNA methylation regulates MicroRNA expression. Cancer Biol. Ther. 6, 1284-1288 (2007).
35. Sessa, L. et al. Noncoding RNA synthesis and loss of Polycomb group repression accompanies the colinear activation of the human HOXA cluster. RNA 13, 223-239 (2007).
36. Sasaki, Y. T., Sano, M., Kin, T., Asai, K. & Hirose, T. Coordinated expression of ncRNAs and HOX mRNAs in the human HOXA locus. Biochem. Biophys. Res. Commun. 357, 724-730 (2007).
37. Petruk, S., Sedkov, Y., Brock, H. W. & Mazo, A. A model for initiation of mosaic HOX gene expression patterns by non-coding RNAs in early embryos. RNA Biol. 4, 1-6 (2007).
38. Rinn, J. L. et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129, 1311-1323 (2007).
39. Gupta, R.A., et al. Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature (in the press). 2010.
40. Khalil, A. M. et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc. Natl Acad. Sci. USA 106, 11667-11672 (2009).
41. Takahashi, O. et al. Dysregulated expression of HOX and ParaHOX genes in human esophageal squamous cell carcinoma. Oncol. Rep. 17, 753-760 (2007).
42. Jung, C. et al. HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation. Br. J. Cancer 92, 2233-2239 (2005).
43. Ghannam, G. et al. The oncogene Nup98-HOXA9 induces gene transcription in myeloid cells. J. Biol. Chem. 279, 866-875 (2004).
44. Lawrence, H. J. et al. Mice bearing a targeted interruption of the homeobox gene HOXA9 have defects in myeloid, erythroid, and lymphoid hematopoiesis. Blood 89, 1922-1930 (1997).
45. Lu, Q. & Kamps, M. P. Heterodimerization of Hox proteins with Pbx1 and oncoprotein E2a-Pbx1 generates unique DNA-binding specifities at nucleotides predicted to contact the N-terminal arm of the Hox homeodomain\demonstration of Hox-dependent targeting of E2a-Pbx1 in vivo. Oncogene 14, 75-83 (1997).
46. Crijns, A. P. et al. MEIS and PBX homeobox proteins in ovarian cancer. Eur. J. Cancer 43, 2495-2505 (2007).
47. Kawagoe, H., Humphries, R. K., Blair, A., Sutherland, H. J. & Hogge, D. E. Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells. Leukemia 13, 687-698 (1999).
48. Shimamoto, T., Ohyashiki, K., Toyama, K. & Takeshita, K. Homeobox genes in hematopoiesis and leukemogenesis. Int. J. Hematol. 67, 339-350 (1998).
49. Laurent, A., Bihan, R., Omilli, F., Deschamps, S. & Pellerin, I. PBX proteins: much more than Hox cofactors. Int. J. Dev. Biol. 52, 9-20 (2008).
50. Myers, C., Charboneau, A., Cheung, I., Hanks, D. & Boudreau, N. Sustained expression of homeobox D10 inhibits angiogenesis. Am. J. Pathol. 161, 2099-2109 (2002).
51. Hansen, S. L., Dosanjh, A., Young, D. M., Boudreau, N. & Hoffman, W. Y. Hemangiomas and homeobox gene expression. J. Craniofac Surg. 17, 767-771 (2006).
52. Myers, C., Charboneau, A. & Boudreau, N. Homeobox B3 promotes capillary morphogenesis and angiogenesis. J. Cell Biol. 148, 343-351 (2000).
53. Huang, L., Pu, Y., Hepps, D., Danielpour, D. & Prins, G. S. Posterior Hox gene expression and differential androgen regulation in the developing and adult rat prostate lobes. Endocrinology 148, 1235-1245 (2007).
54. Trivedi, C. M., Patel, R. C. & Patel, C. V. Homeobox gene HOXA9 inhibits nuclear factor-κB dependent activation of endothelium. Atherosclerosis 195, e50-e60 (2007).
55. McMullin, R. P., Mutton, L. N. & Bieberich, C. J. Hoxb13 regulatory elements mediate transgene expression during prostate organogenesis and carcinogenesis. Dev. Dyn. 238, 664-672 (2009).
56. Patel, C. V., Sharangpani, R., Bandyopadhyay, S. & DiCorleto, P. E. Endothelial cells express a novel, tumor necrosis factor-alpha-regulated variant of HOXA9. J. Biol. Chem. 274, 1415-1422 (1999).
57. Trivedi, C. M., Patel, R. C. & Patel, C. V. Differential regulation of HOXA9 expression by nuclear factor kappa B (NF-κB) and HOXA9. Gene 408, 187-195 (2008).
58. Park, J. R., Eggert, A. & Caron, H. Neuroblastoma: biology, prognosis, and treatment. Pediatr. Clin. North Am. 55, 97-120 (2008).
59. Abbracchio, M. P., Cattabeni, F., Clementi, F. & Sher, E. Adenosine receptors linked to adenylate cyclase activity in human neuroblastoma cells: modulation during cell differentiation. Neuroscience 30, 819-825 (1989).
60. Horii, Y. et al. Differential expression of N-myc and c-src proto-oncogenes during neuronal and schwannian differentiation of human neuroblastoma cells. Int. J. Cancer 43, 305-309 (1989). (Pubitemid 19062429)
61. Manohar, C. F., Salwen, H. R., Furtado, M. R. & Cohn, S. L. Up-regulation of HOXC6, HOXD1, and HOXD8 homeobox gene expression in human neuroblastoma cells following chemical induction of differentiation. Tumour Biol. 17, 34-47 (1996).
62. Jung, C., Kim, R. S., Zhang, H. J., Lee, S. J. & Jeng, M. H. HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone-activated androgen receptor signaling. Cancer Res. 64, 9185-9192 (2004).
63. Miller, G. J. et al. Aberrant HOXC expression accompanies the malignant phenotype in human prostate. Cancer Res. 63, 5879-5888 (2003).
64. Waltregny, D., Alami, Y., Clausse, N., de Leval, J. & Castronovo, V. Overexpression of the homeobox gene HOXC8 in human prostate cancer correlates with loss of tumor differentiation. Prostate 50, 162-169 (2002).
65. Kikugawa, T. et al. PLZF regulates Pbx1 transcription and Pbx1-HoxC8 complex leads to androgen-independent prostate cancer proliferation. Prostate 66, 1092-1099 (2006).
66. Cheng, W., Liu, J., Yoshida, H., Rosen, D. & Naora, H. Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tract. Nature Med. 11, 531-537 (2005).
67. Dubeau, L. The cell of origin of ovarian epithelial tumors and the ovarian surface epithelium dogma: does the emperor have no clothes? Gynecol. Oncol. 72, 437-442 (1999).
68. Lawrence, H. J., Sauvageau, G., Humphries, R. K. & Largman, C. The role of HOX homeobox genes in normal and leukemic hematopoiesis. Stem Cells 14, 281-291 (1996).
69. Bijl, J. et al. Expression of HOXC4, HOXC5, and HOXC6 in human lymphoid cell lines, leukemias, and benign and malignant lymphoid tissue. Blood 87, 1737-1745 (1996).
70. Armstrong, S. A. et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nature Genet. 30, 41-47 (2002).
71. Ayton, P. M. & Cleary, M. L. Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. Genes Dev. 17, 2298-2307 (2003).
72. Rubin, E. et al. A role for the HOXB7 homeodomain protein in DNA repair. Cancer Res. 67, 1527-1535 (2007).
73. Chen, H. et al. Hoxb7 inhibits transgenic HER-2/neu-induced mouse mammary tumor onset but promotes progression and lung metastasis. Cancer Res. 68, 3637-3644 (2008).
74. Chirnomas, D. et al. Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway. Mol. Cancer Ther. 5, 952-961 (2006).
75. Ma, X. J. et al. A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 5, 607-616 (2004).
76. Jerevall, P. L. et al. Exploring the two-gene ratio in breast cancer\independent roles for HOXB13 and IL17BR in prediction of clinical outcome. Breast Cancer Res. Treat 107, 225-234 (2008).
77. Ma, X. J. et al. Gene expression profiles of human breast cancer progression. Proc. Natl Acad. Sci. USA 100, 5974-5979 (2003).
78. Raman, V. et al. Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature 405, 974-978 (2000).
79. Chen, H., Chung, S. & Sukumar, S. HOXA5-induced apoptosis in breast cancer cells is mediated by caspases 2 and 8. Mol. Cell. Biol. 24, 924-935 (2004).
80. Gendronneau, G. et al. Influence of Hoxa5 on p53 tumorigenic outcome in mice. Am. J. Pathol. 176, 995-1005 (2010).
81. Chu, M. C., Selam, F. B. & Taylor, H. S. HOXA10 regulates p53 expression and matrigel invasion in human breast cancer cells. Cancer Biol. Ther. 3, 568-572 (2004).
82. Plowright, L., Harrington, K. J., Pandha, H. S. & Morgan, R. HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer). Br. J. Cancer 100, 470-475 (2009).
83. Morgan, R. et al. Antagonism of HOX/PBX dimer formation blocks the in vivo proliferation of melanoma. Cancer Res. 67, 5806-5813 (2007).
84. Kasibhatla, S. et al. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-κB and AP-1. Mol. Cell 1, 543-551 (1998).
85. Argiropoulos, B. & Humphries, R. K. Hox genes in hematopoiesis and leukemogenesis. Oncogene 26, 6766-6776 (2007).
86. Lawrence, H. J. & Largman, C. Homeobox genes in normal hematopoiesis and leukemia. Blood 80, 2445-2453 (1992).
87. Hu, Y. L., Fong, S., Ferrell, C., Largman, C. & Shen, W. F. HOXA9 modulates its oncogenic partner Meis1 to influence normal hematopoiesis. Mol. Cell. Biol. 29, 5181-5192 (2009).
88. Whelan, J. T., Ludwig, D. L. & Bertrand, F. E. HoxA9 induces insulin-like growth factor-1 receptor expression in B-lineage acute lymphoblastic leukemia. Leukemia 22, 1161-1169 (2008).
89. Carrio, M., Arderiu, G., Myers, C. & Boudreau, N. J. Homeobox D10 induces phenotypic reversion of breast tumor cells in a three-dimensional culture model. Cancer Res. 65, 7177-7185 (2005).
90. Daftary, G. S. & Taylor, H. S. Endocrine regulation of HOX genes. Endocr. Rev. 27, 331-355 (2006).
91. Loi, S. et al. Gene expression profiling identifies activated growth factor signaling in poor prognosis (Luminal-B) estrogen receptor positive breast cancer. BMC Med. Genomics 2, 37 (2009).
92. Qiu, Y. et al. Pre-B-cell leukemia transcription factor 1 regulates expression of valosin-containing protein, a gene involved in cancer growth. Am. J. Pathol. 170, 152-159 (2007).
93. Crickmore, M. A., Ranade, V. & Mann, R. S. Regulation of Ubx expression by epigenetic enhancer silencing in response to Ubx levels and genetic variation. PLoS Genet. 5, e1000633 (2009).
94. Kannan, R., Berger, C., Myneni, S., Technau, G. M. & Shashidhara, L. S. Abdominal-A mediated repression of Cyclin E expression during cell-fate specification in the Drosophila central nervous system. Mech. Dev. 127, 137-145 (2009).
95. Leucht, P. et al. Embryonic origin and Hox status determine progenitor cell fate during adult bone regeneration. Development 135, 2845-2854 (2008).
96. Karnoub, A. E. et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449, 557-563 (2007).
97. Korkaya, H. & Wicha, M. S. HER-2, notch, and breast cancer stem cells: targeting an axis of evil. Clin. Cancer Res. 15, 1845-1847 (2009).
98. Wang, G. G., Cai, L., Pasillas, M. P. & Kamps, M. P. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis. Nature Cell Biol. 9, 804-812 (2007).
99. Yang, Y. C. et al. A tumorigenic homeobox (HOX) gene expressing human gastric cell line derived from putative gastric stem cell. Eur. J. Gastroenterol. Hepatol 21, 1016-1023 (2009).
100. Palmqvist, L., Pineault, N., Wasslavik, C. & Humphries, R. K. Candidate genes for expansion and transformation of hematopoietic stem cells by NUP98-HOX fusion genes. PLoS ONE 2, e768 (2007).
101. Wong, P., Iwasaki, M., Somervaille, T. C., So, C. W. & Cleary, M. L. Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential. Genes D e v. 21, 2762-2774 (2007).
102. Chou, W. C. et al. Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: comparative analysis of 493 adult patients. Leukemia 23, 1303-1310 (2009).
103. Goetz, M. P. et al. A two-gene expression ratio of homeoBOX 13 and interleukin-17B receptor for prediction of recurrence and survival in women receiving adjuvant tamoxifen. Clin. Cancer Res. 12, 2080-2087 (2006).
104. Jansen, M. P. et al. HOXB13-to-IL17BR expression ratio is related with tumor aggressiveness and response to tamoxifen of recurrent breast cancer: a retrospective study. J. Clin. Oncol. 25, 662-668 (2007).
105. Zaremba, T. & Curtin, N. J. PARP inhibitor development for systemic cancer targeting. Anticancer Agents Med. Chem. 7, 515-523 (2007).
106. Kmita, M. et al. Early developmental arrest of mammalian limbs lacking HoxA/HoxD gene function. Nature 435, 1113-1116 (2005).
107. Dhanasekaran, S. M. et al. Molecular profiling of human prostate tissues: insights into gene expression patterns of prostate development during puberty. FASEB J. 19, 243-245 (2005).
108. Yahagi, N. et al. Position-specific expression of Hox genes along the gastrointestinal tract. Congenit Anom (Kyoto) 44, 18-26 (2004).
109. Volpe, M. V. et al. Aberrant cell adhesion molecule expression in human bronchopulmonary sequestration and congenital cystic adenomatoid malformation. Am. J. Physiol. Lung Cell. Mol. Physiol. 297, L143-L152 (2009).
110. Goodman, F. R. Limb malformations and the human HOX genes. Am. J. Med. Genet. 11 2, 256-265 (2002).
111. Maeda, Y., Dave, V. & Whitsett, J. A. Transcriptional control of lung morphogenesis. Physiol. Rev. 87, 219-244 (2007).
112. Abramovich, C., Pineault, N., Ohta, H. & Humphries, R. K. Hox genes: from leukemia to hematopoietic stem cell expansion. Ann. NY Acad. Sci. 1044, 109-116 (2005).
113. Lawrence, H. J. et al. Loss of expression of the Hoxa-9 homeobox gene impairs the proliferation and repopulating ability of hematopoietic stem cells. Blood 106, 3988-3994 (2005).
114. Thorsteinsdottir, U., Sauvageau, G. & Humphries, R. K. Hox homeobox genes as regulators of normal and leukemic hematopoiesis. Hematol. Oncol. Clin. North Am. 11, 1221-1237 (1997). (Pubitemid 28028699)
115. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920 (2007).
116. Nakagawa, M. et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nature Biotechnol. 26, 101-106 (2008).
117. Atkinson, S. P. et al. Epigenetic marking prepares the human HOXA cluster for activation during differentiation of pluripotent cells. Stem Cells 26, 1174-1185 (2008).
118. Gouti, M. & Gavalas, A. Hoxb1 controls cell fate specification and proliferative capacity of neural stem and progenitor cells. Stem Cells 26, 1985-1997 (2008).
119. Abramovich, C. & Humphries, R. K. Hox regulation of normal and leukemic hematopoietic stem cells. Curr. Opin. Hematol. 12, 210-216 (2005).
120. Naguibneva, I. et al. The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation. Nature Cell Biol. 8, 278-284 (2006).
121. Charboneau, A., East, L., Mulholland, N., Rohde, M. & Boudreau, N. Pbx1 is required for Hox D3-mediated angiogenesis. Angiogenesis 8, 289-296 (2005).
122. Shen, W., Chrobak, D., Krishnan, K., Lawrence, H. J. & Largman, C. HOXB6 protein is bound to CREB-binding protein and represses globin expression in a DNA binding-dependent, PBX interaction-independent process. J. Biol. Chem. 279, 39895-39904 (2004).
123. Li, X., Nie, S., Chang, C., Qiu, T. & Cao, X. Smads oppose Hox transcriptional activities. Exp. Cell Res. 312, 854-864 (2006).
124. Abe, M. et al. Disordered expression of HOX genes in human non-small cell lung cancer. Oncol. Rep. 15, 797-802 (2006).
125. Alami, Y., Castronovo, V., Belotti, D., Flagiello, D. & Clausse, N. HOXC5 and HOXC8 expression are selectively turned on in human cervical cancer cells compared to normal keratinocytes. Biochem. Biophys. Res. Commun. 257, 738-745 (1999)
126. Lewis, E. B. Pseudoallelism and gene evolution. Cold Spring Harb. Symp. Quant. Biol. 16, 159-174 (1951).
127. Lewis, E. B. A gene complex controlling segmentation in Drosophila. Nature 276, 565-570 (1978).
128. Kaufman, T. C., Lewis, R. & Wakimoto, B. Cytogenetic Analysis of Chromosome 3 in DROSOPHILA MELANOGASTER: The Homoeotic Gene Complex in Polytene Chromosome Interval 84a-B. Genetics 94, 115-133 (1980). (Pubitemid 10037865)
129. Scott, M. P. et al. The molecular organization of the Antennapedia locus of Drosophila. Cell 35, 763-776 (1983).
130. Garber, R. L., Kuroiwa, A. & Gehring, W. J. Genomic and cDNA clones of the homeotic locus Antennapedia in Drosophila. EMBO J. 2, 2027-2036 (1983).
131. Duboule, D., Baron, A., Mahl, P. & Galliot, B. A new homeo-box is present in overlapping cosmid clones which define the mouse Hox-1 locus. EMBO J. 5, 1973-1980 (1986).
132. Hart, C. P., Awgulewitsch, A., Fainsod, A., McGinnis, W. & Ruddle, F. H. Homeo box gene complex on mouse chromosome 11: molecular cloning, expression in embryogenesis, and homology to a human homeo box locus. Cell 43, 9-18 (1985).
133. Lonai, P., Arman, E., Czosnek, H., Ruddle, F. H. & Blatt, C. New murine homeoboxes: structure, chromosomal assignment, and differential expression in adult erythropoiesis. DNA 6, 409-418 (1987).
134. Kongsuwan, K., Webb, E., Housiaux, P. & Adams, J. M. Expression of multiple homeobox genes within diverse mammalian haemopoietic lineages. EMBO J. 7, 2131-2138 (1988).
135. Kamps, M. P., Murre, C., Sun, X. H. & Baltimore, D. A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell 60, 547-555 (1990).
136. Nourse, J. et al. Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 60, 535-545 (1990).
137. Zeltser, L., Desplan, C. & Heintz, N. Hoxb-13: a new Hox gene in a distant region of the HOXB cluster maintains colinearity. Development 122, 2475-2484 (1996).
138. Biondi, A., Cimino, G., Pieters, R. & Pui, C. H. Biological and therapeutic aspects of infant leukemia. Blood 96, 24-33 (2000).
139. Yekta, S., Shih, I. H. & Bartel, D. P. MicroRNA-directed cleavage of HOXB8 mRNA. Science 304, 594-596 (2004).